274 related articles for article (PubMed ID: 19259097)
21. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
23. Incidence of myeloid malignancies by subtype in Hong Kong and comparisons with Asian and white men and women in the United States.
Bassig BA; Hu W; Morton LM; Ji BT; Xu J; Linet MS; Kwong YL; Rothman N; Wong KF; Lan Q
Leuk Lymphoma; 2022 Aug; 63(8):1917-1924. PubMed ID: 35412943
[TBL] [Abstract][Full Text] [Related]
24. Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?
Hochman MJ; DeZern AE
Lancet Haematol; 2022 Jul; 9(7):e523-e534. PubMed ID: 35772431
[TBL] [Abstract][Full Text] [Related]
25. Myeloid disorders after autoimmune disease.
Boddu PC; Zeidan AM
Best Pract Res Clin Haematol; 2019 Mar; 32(1):74-88. PubMed ID: 30927978
[TBL] [Abstract][Full Text] [Related]
26. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.
Enright H; Jacob HS; Vercellotti G; Howe R; Belzer M; Miller W
Br J Haematol; 1995 Oct; 91(2):403-8. PubMed ID: 8547082
[TBL] [Abstract][Full Text] [Related]
27. Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.
Maynadié M; De Angelis R; Marcos-Gragera R; Visser O; Allemani C; Tereanu C; Capocaccia R; Giacomin A; Lutz JM; Martos C; Sankila R; Johannesen TB; Simonetti A; Sant M;
Haematologica; 2013 Feb; 98(2):230-8. PubMed ID: 22983589
[TBL] [Abstract][Full Text] [Related]
28. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
Kaplan H; Malmgren J; De Roos AJ
Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
[TBL] [Abstract][Full Text] [Related]
29. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
30. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.
Srour SA; Devesa SS; Morton LM; Check DP; Curtis RE; Linet MS; Dores GM
Br J Haematol; 2016 Aug; 174(3):382-96. PubMed ID: 27061824
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.
Rollison DE; Howlader N; Smith MT; Strom SS; Merritt WD; Ries LA; Edwards BK; List AF
Blood; 2008 Jul; 112(1):45-52. PubMed ID: 18443215
[TBL] [Abstract][Full Text] [Related]
32. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.
Kaplan HG; Malmgren JA; Li CI; Calip GS
Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women.
Schairer C; Pfeiffer RM; Gadalla SM
Int J Cancer; 2018 Mar; 142(6):1202-1208. PubMed ID: 29144542
[TBL] [Abstract][Full Text] [Related]
35. The relationship between myelodysplastic syndromes and autoimmune disorders.
Zhao S; Mao H; Wang H; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):311-3. PubMed ID: 12411063
[TBL] [Abstract][Full Text] [Related]
36. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
[TBL] [Abstract][Full Text] [Related]
37. Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database.
Morice PM; Leary A; Dolladille C; Chrétien B; Poulain L; González-Martín A; Moore K; O'Reilly EM; Ray-Coquard I; Alexandre J
Lancet Haematol; 2021 Feb; 8(2):e122-e134. PubMed ID: 33347814
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment.
Sevcikova K; Zhuang Z; Garcia-Manero G; Alvarez RH; Kantarjian HM; Mego M; Albarracin C; Tang G; Strom SS; Medeiros LJ; Hortobagyi GN; Reuben JM; Khoury JD
Leukemia; 2016 Jan; 30(1):242-7. PubMed ID: 25975189
[No Abstract] [Full Text] [Related]
40. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.
Aul C; Gattermann N; Schneider W
Br J Haematol; 1992 Oct; 82(2):358-67. PubMed ID: 1419819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
